BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37031532)

  • 1. A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance.
    Doghish AS; Hegazy M; Ismail A; El-Mahdy HA; Elsakka EGE; Elkhawaga SY; Elkady MA; Yehia AM; Abdelmaksoud NM; Mokhtar MM
    Pathol Res Pract; 2023 May; 245():154442. PubMed ID: 37031532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways.
    Abdelmaksoud NM; El-Mahdy HA; Ismail A; Elsakka EGE; El-Husseiny AA; Khidr EG; Ali EM; Rashed MH; El-Demerdash FE; Doghish AS
    Pathol Res Pract; 2023 Apr; 244():154411. PubMed ID: 36921547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses.
    El-Mahdy HA; Mohamadin AM; Abulsoud AI; Khidr EG; El-Husseiny AA; Ismail A; Elsakka EGE; Mokhlis HA; El-Husseiny HM; Doghish AS
    Pathol Res Pract; 2023 May; 245():154457. PubMed ID: 37058745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway.
    Dong L; Qu F
    J Mol Histol; 2020 Aug; 51(4):329-340. PubMed ID: 32472335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G; Zhang C; Wang N; Chen J
    Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
    Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
    Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as the pivotal regulators of cisplatin resistance in osteosarcoma.
    Moghbeli M
    Pathol Res Pract; 2023 Sep; 249():154743. PubMed ID: 37549518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
    Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis.
    Xia P; Gu R; Zhang W; Shao L; Li F; Wu C; Sun Y
    J Cell Physiol; 2019 Dec; 234(12):22787-22798. PubMed ID: 31152456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-221 Promotes Cell Proliferation and Inhibits Apoptosis in Osteosarcoma Cells by Directly Targeting FBXW11 and Regulating Wnt Signaling.
    Zhang Q; Yin X; Zhang Y
    Arch Med Res; 2021 Feb; 52(2):191-199. PubMed ID: 33131925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway.
    Liu Y; Wang Y; Yang H; Zhao L; Song R; Tan H; Wang L
    Int J Oncol; 2019 May; 54(5):1809-1820. PubMed ID: 30816476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z; Jiang C; Fang J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity.
    Soghli N; Ferns GA; Sadeghsoltani F; Qujeq D; Yousefi T; Vaghari-Tabari M
    Biochem Pharmacol; 2022 Jul; 201():115094. PubMed ID: 35588853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.
    Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Deng Y
    Cell Cycle; 2019 Dec; 18(23):3325-3336. PubMed ID: 31601147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
    Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells.
    Li Z; Li Y; Wang N; Yang L; Zhao W; Zeng X
    Biochem Biophys Res Commun; 2016 Mar; 471(4):479-85. PubMed ID: 26902120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-1247 inhibits the viability and metastasis of osteosarcoma cells via targeting NRP1 and mediating Wnt/β-catenin pathway.
    Wei QF; Yao JS; Yang YT
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7266-7274. PubMed ID: 31539113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC01128 regulates the development of osteosarcoma by sponging miR-299-3p to mediate MMP2 expression and activating Wnt/β-catenin signalling pathway.
    Yao Q; Chen T
    J Cell Mol Med; 2020 Dec; 24(24):14293-14305. PubMed ID: 33108067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.